Senzar Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q2 | – | Sell |
-558,889
| Closed | -$29.9M | – | 44 |
|
2016
Q1 | $29.9M | Sell |
558,889
-722,300
| -56% | -$38.7M | 5.94% | 4 |
|
2015
Q4 | $84.1M | Buy |
1,281,189
+66,695
| +5% | +$4.38M | 9.35% | 3 |
|
2015
Q3 | $68.6M | Buy |
1,214,494
+336,997
| +38% | +$19M | 9.97% | 3 |
|
2015
Q2 | $51.9M | Buy |
877,497
+326,300
| +59% | +$19.3M | 8.91% | 2 |
|
2015
Q1 | $34.3M | Buy |
551,197
+320,300
| +139% | +$20M | 8.37% | 3 |
|
2014
Q4 | $13.3M | Sell |
230,897
-337,499
| -59% | -$19.4M | 3.89% | 6 |
|
2014
Q3 | $30.6M | Buy |
568,396
+77,400
| +16% | +$4.16M | 8.96% | 3 |
|
2014
Q2 | $25.7M | Buy |
490,996
+50,596
| +11% | +$2.65M | 9.83% | 1 |
|
2014
Q1 | $23.3M | Buy |
440,400
+95,100
| +28% | +$5.03M | 12.32% | 3 |
|
2013
Q4 | $13.8M | Buy |
+345,300
| New | +$13.8M | 11.31% | 2 |
|